Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: A pilot study

Overview of attention for article published in BMC Cancer, January 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 30,277 followers.

[VEGF] Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellul... http://t.co/GJmwYFjI PM

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer:... http://t.co/CtHHaMBR

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer:... http://t.co/tiXuXpBC

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer:... http://t.co/LGtSBT4U

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.